[25] Mechanism of action [edit] Dulaglutide binds to glucagon-like peptide 1 receptors, slowing gastric emptying and increasing insulin secretion by pancreatic Beta cells
The majority of GLP-1s are produced by L-cells lining the small intestine and colon
By bridging these gaps, GLP-1RAs could herald a new era in pain management, offering hope for patients with refractory or complex pain conditions
The choice between medications should consider individual tolerance, weight loss efficacy, and other factors
Risk to health [We advise] healthcare professionals, regulatory authorities and the public be aware of these falsified batches of medicines, said Dr Yukiko Nakatani, WHO assistant director general for essential medicines and health products
Exclusivity on the peptides has proven robust because the claim protects the key peptide and, even though the generic scope may be limited, there is little structural room for a successful follow-on outside the claim